Demographics, methods of use, and perceived benefits among patients with cancer who use cannabis.
This study examines demographics cannabis use cancer patients, focusing on reasons, methods, and perceived benefits. Nearly 25% of surveyed cancer patients reported cannabis use. The findings provide insight into patient behaviors and symptom management.
The Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview
The CAN-PACT program focuses on psychedelic-assisted therapy cancer patients to address demoralization syndrome. This multi-phase initiative aims to improve supportive care for advanced cancer patients. It establishes clinical infrastructure and training…
Potency-Related Effects of Smoked Cannabis on Driving Performance
This randomized trial investigates cannabis driving impairment effects linked to smoked cannabis potency. The study provides evidence on how THC levels affect simulated driving performance. These findings inform clinical counseling and patient safety…
Cannabinol for Acute Treatment of Insomnia Disorder in a Randomized Trial
This cannabinol insomnia disorder trial investigates CBN's potential as a treatment for sleep disturbances. The randomized placebo-controlled crossover study uses objective sleep measurements. Results provide new insights into CBN's role in insomnia…
Efficacy and Safety of Cannabidiol Oil in Psoriasis: A Randomized Trial
This randomized trial evaluated cannabidiol oil psoriasis safety and efficacy in patients with chronic plaque psoriasis. While PASI score improvement was not significant, cannabidiol oil reduced itch scores. The study supports cannabidiol oil psoriasis…
Racial Diversity in Cannabis Use Disorder Research: A Systematic Review
Racial diversity cannabis use disorder research reveals significant underrepresentation of people of color in clinical trials. This gap impacts the development of culturally adapted treatments for cannabis use disorder. Addressing these disparities is…
Vaporized Cannabis vs Placebo for Acute Migraine: A Randomized Trial
This randomized trial evaluates vaporized cannabis acute migraine treatment. The THC+CBD combination showed significant pain relief compared to placebo. These findings support cannabis as a potential option for acute migraine care.
Clinical Research on CBD’s Impact on Hippocampal Glutamate in Psychosis
CBD hippocampal glutamate modulation psychosis research reveals how a single dose of CBD affects brain activity during memory tasks. This modulation may normalize disrupted glutamate signaling in early psychosis. These findings highlight CBD’s potential…
Topical Cannabis for AIMSS: Medical Cannabis Evidence
This study evaluates topical cannabinoid application feasibility in postmenopausal breast cancer patients with AIMSS. The trial found topical cannabis balms to be well tolerated. These results support further research on topical cannabinoid application…
Cannabidiol Drug Interactions: Clinical Evidence Review
Cannabidiol drug interactions clinical evidence highlights CBD's potential to interact with multiple drug classes, especially opioids. Careful medication review is essential before starting CBD in patients on complex regimens. Clinicians should treat CBD…
